Geneos Wealth Management’s VanEck CLO ETF CLOI Stock Holding History

Geneos Wealth Management’s Portfolio CLOI Stock Details CLOI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.3M	Buy	195,715 +38,797	+25%	+$2.05M	0.24%	95
2025 Q4	$8.29M	Sell	156,918 -5,010	-3%	-$265K	0.2%	128
2025 Q3	$8.6M	Buy	161,928 +8,425	+5%	+$446K	0.22%	117
2025 Q2	$8.13M	Sell	153,503 -87,930	-36%	-$4.63M	0.2%	130
2025 Q1	$12.8M	Buy	241,433 +231,849	+2,419%	+$12.3M	0.18%	137
2024 Q4	$506K	Buy	+9,584	New	+$508K	0.02%	586

Other funds holding CLOI

IAA

Independence Asset Advisors Wynnewood,, Pennsylvania $384M AUM 10.81% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return

TPWA

TRUE Private Wealth Advisors Salem, Oregon $1.05B AUM 19.14% 1-Year Est. Return

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

SWA

Sax Wealth Advisors Parsippany, New Jersey $2.46B AUM 19.75% 1-Year Est. Return

DMBA

Deseret Mutual Benefit Administrators Salt Lake City, Utah $294M AUM 19.14% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return

DWP

Destiny Wealth Partners Tavares, Florida $914M AUM 18.14% 1-Year Est. Return

DWM

Darwin Wealth Management Tampa, Florida $365M AUM 22.69% 1-Year Est. Return

Geneos Wealth Management's CLOI Position: Q1 2026 in Review

Geneos Wealth Management increased its VanEck CLO ETF (CLOI) stake by 25% in Q1 2026, buying an estimated $2.05M and bringing the position to 195,715 shares worth $10.3M. The position accounts for 0.24% of the portfolio, ranked #95.

Geneos Wealth Management first reported a position in CLOI in Q4 2024 and has held it in 6 quarters since. The position peaked at $12.8M in Q1 2025. 167 funds tracked by Wall St. Rank hold CLOI as of Q1 2026.

Geneos Wealth Management held 195,715 shares of VanEck CLO ETF worth $10.3M as of Q1 2026.
Geneos Wealth Management bought 38,797 VanEck CLO ETF shares in Q1 2026, an estimated $2.05M.
VanEck CLO ETF made up 0.24% of Geneos Wealth Management's portfolio in Q1 2026, its #95 holding.
Geneos Wealth Management first reported a position in VanEck CLO ETF in Q4 2024 and has held it in 6 quarters since.
Geneos Wealth Management's VanEck CLO ETF position peaked at $12.8M in Q1 2025.
167 funds tracked by Wall St. Rank held VanEck CLO ETF as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.